Loading...

AquaBounty Technologies

BST:W8NB
Snowflake Description

Adequate balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
W8NB
BST
$48M
Market Cap
  1. Home
  2. DE
  3. Pharmaceuticals & Biotech
Company description

AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. The last earnings update was 19 days ago. More info.


Add to Portfolio Compare Print
W8NB Share Price and Events
7 Day Returns
7.3%
BST:W8NB
3.8%
DE Biotechs
0.3%
DE Market
1 Year Returns
-
BST:W8NB
-8%
DE Biotechs
-11.6%
DE Market
W8NB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
AquaBounty Technologies (W8NB) 7.3% -2.8% - - - -
DE Biotechs 3.8% 3.9% 0.2% -8% 57.7% 11.4%
DE Market 0.3% -3.8% 2.5% -11.6% 10.1% 7.9%
1 Year Return vs Industry and Market
  • No trading data on W8NB.
  • No trading data on W8NB.
Price Volatility
W8NB
Industry
5yr Volatility vs Market

Value

 Is AquaBounty Technologies undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for AquaBounty Technologies. This is due to cash flow or dividend data being unavailable. The share price is €1.942.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for AquaBounty Technologies's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are AquaBounty Technologies's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:W8NB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.90
NasdaqCM:AQB Share Price ** NasdaqCM (2019-05-21) in USD $2.2
Europe Biotechs Industry PE Ratio Median Figure of 29 Publicly-Listed Biotechs Companies 20.93x
Germany Market PE Ratio Median Figure of 423 Publicly-Listed Companies 20.29x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of AquaBounty Technologies.

BST:W8NB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:AQB Share Price ÷ EPS (both in USD)

= 2.2 ÷ -0.90

-2.45x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • AquaBounty Technologies is loss making, we can't compare its value to the Europe Biotechs industry average.
  • AquaBounty Technologies is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does AquaBounty Technologies's expected growth come at a high price?
Raw Data
BST:W8NB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -2.45x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
15.8%per year
Europe Biotechs Industry PEG Ratio Median Figure of 23 Publicly-Listed Biotechs Companies 1.22x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.5x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for AquaBounty Technologies, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on AquaBounty Technologies's assets?
Raw Data
BST:W8NB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $1.47
NasdaqCM:AQB Share Price * NasdaqCM (2019-05-21) in USD $2.2
Germany Biotechs Industry PB Ratio Median Figure of 14 Publicly-Listed Biotechs Companies 3.34x
Germany Market PB Ratio Median Figure of 576 Publicly-Listed Companies 1.79x
BST:W8NB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:AQB Share Price ÷ Book Value per Share (both in USD)

= 2.2 ÷ 1.47

1.49x

* Primary Listing of AquaBounty Technologies.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • AquaBounty Technologies is good value based on assets compared to the DE Biotechs industry average.
X
Value checks
We assess AquaBounty Technologies's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Biotechs industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Biotechs industry average (and greater than 0)? (1 check)
  5. AquaBounty Technologies has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is AquaBounty Technologies expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
15.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is AquaBounty Technologies expected to grow at an attractive rate?
  • Unable to compare AquaBounty Technologies's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare AquaBounty Technologies's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • AquaBounty Technologies's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:W8NB Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:W8NB Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 15.8%
BST:W8NB Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 57%
Germany Biotechs Industry Earnings Growth Rate Market Cap Weighted Average 52.5%
Germany Biotechs Industry Revenue Growth Rate Market Cap Weighted Average 32.7%
Germany Market Earnings Growth Rate Market Cap Weighted Average 13%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:W8NB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:W8NB Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 31 1
2022-12-31 20 1
2021-12-31 15 1
2020-12-31 5 -9 2
2019-12-31 0 -10 1
BST:W8NB Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 0 -9 -13
2018-12-31 0 -10 -12
2018-09-30 0 -10 -11
2018-06-30 0 -10 -10
2018-03-31 0 -9 -10
2017-12-31 0 -9 -9
2017-09-30 0 -9 -9
2017-06-30 0 -8 -9
2017-03-31 -8 -9
2016-12-31 -7 -8
2016-09-30 -7 -8
2016-06-30 -7 -7

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • AquaBounty Technologies is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • AquaBounty Technologies's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:W8NB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from AquaBounty Technologies Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:W8NB Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31 -0.43 -0.40 -0.45 2.00
2019-12-31 -0.53 -0.53 -0.53 1.00
BST:W8NB Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.90
2018-12-31 -0.94
2018-09-30 -0.91
2018-06-30 -0.97
2018-03-31 -1.00
2017-12-31 -1.06
2017-09-30 -1.14
2017-06-30 -1.25
2017-03-31 -1.43
2016-12-31 -1.60
2016-09-30 -1.50
2016-06-30 -1.41

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if AquaBounty Technologies will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess AquaBounty Technologies's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
AquaBounty Technologies has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has AquaBounty Technologies performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare AquaBounty Technologies's growth in the last year to its industry (Biotechs).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • AquaBounty Technologies does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare AquaBounty Technologies's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare AquaBounty Technologies's 1-year growth to the Europe Biotechs industry average as it is not currently profitable.
Earnings and Revenue History
AquaBounty Technologies's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from AquaBounty Technologies Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:W8NB Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 0.16 -12.52 7.55 3.14
2018-12-31 0.08 -12.20 6.91 3.46
2018-09-30 0.08 -10.62 7.09 3.52
2018-06-30 0.07 -10.34 6.75 3.57
2018-03-31 0.07 -9.65 6.00 3.63
2017-12-31 0.05 -9.26 5.86 3.37
2017-09-30 0.05 -9.04 5.62 3.24
2017-06-30 0.05 -8.74 5.07 3.35
2017-03-31 -8.71 4.98 3.33
2016-12-31 -8.47 4.64 3.43
2016-09-30 -7.86 3.97 3.65
2016-06-30 -7.38 3.43 3.84
2016-03-31 -7.08 3.52 3.54
2015-12-31 -7.03 3.69 3.34
2015-09-30 -6.81 3.73 3.08
2015-06-30 -7.19 4.61 2.58
2015-03-31 -7.31 4.75 2.56
2014-12-31 -7.13 3.92 3.21
2014-09-30 -7.00 4.71 2.49
2014-06-30 -6.05 4.02 2.22
2014-03-31 -5.34 3.44 2.09
2013-12-31 -4.69 2.98 1.90
2013-09-30 -4.22 2.65 1.57
2013-06-30 -4.16 2.63 1.53
2013-03-31 -4.16 2.59 1.52
2012-12-31 -4.41 2.68 1.63
2012-09-30 -3.37 2.80 1.82
2012-06-30 -2.32 2.92 2.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if AquaBounty Technologies has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if AquaBounty Technologies has efficiently used its assets last year compared to the Europe Biotechs industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if AquaBounty Technologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess AquaBounty Technologies's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Biotechs industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
AquaBounty Technologies has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is AquaBounty Technologies's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up AquaBounty Technologies's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • AquaBounty Technologies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • AquaBounty Technologies's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of AquaBounty Technologies's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from AquaBounty Technologies Company Filings, last reported 1 month ago.

BST:W8NB Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 27.56 4.43 7.64
2018-12-31 23.23 3.59 3.00
2018-09-30 21.53 3.03 1.04
2018-06-30 24.10 2.99 3.53
2018-03-31 26.33 3.06 6.85
2017-12-31 17.98 3.08 0.51
2017-09-30 20.58 3.12 4.73
2017-06-30 22.95 3.01 8.00
2017-03-31 24.96 2.81 25.48
2016-12-31 2.03 2.66 3.34
2016-09-30 -6.00 10.23 3.19
2016-06-30 -3.92 7.22 1.94
2016-03-31 -0.06 2.07 1.32
2015-12-31 -0.06 2.07 1.32
2015-09-30
2015-06-30 3.19 2.32 4.69
2015-03-31 3.51 2.42 5.18
2014-12-31 3.51 2.42 5.18
2014-09-30 5.02 2.52 6.93
2014-06-30 6.90 2.64 8.64
2014-03-31 8.78 2.43 10.10
2013-12-31 0.50 2.36 1.89
2013-09-30
2013-06-30 2.93 2.30 3.95
2013-03-31 -0.78 2.31 0.36
2012-12-31 -0.78 2.31 0.36
2012-09-30 -0.78 2.31 0.36
2012-06-30 1.07 1.74 1.59
  • AquaBounty Technologies's level of debt (16.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (27.8% vs 16.1% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • AquaBounty Technologies has less than a year of cash runway based on current free cash flow.
  • AquaBounty Technologies has less than a year of cash runway if free cash flow continues to grow at historical rates of 21.4% each year.
X
Financial health checks
We assess AquaBounty Technologies's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. AquaBounty Technologies has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is AquaBounty Technologies's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from AquaBounty Technologies dividends.
If you bought €2,000 of AquaBounty Technologies shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate AquaBounty Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate AquaBounty Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:W8NB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Europe Biotechs Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 0.8%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:W8NB Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as AquaBounty Technologies has not reported any payouts.
  • Unable to verify if AquaBounty Technologies's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of AquaBounty Technologies's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as AquaBounty Technologies has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess AquaBounty Technologies's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can AquaBounty Technologies afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. AquaBounty Technologies has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of AquaBounty Technologies's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Sylvia Wulf
AGE 60
TENURE AS CEO 0.3 years
CEO Bio

Ms. Sylvia Wulf has been Chief Executive Officer, President and Executive Director of AquaBounty Technologies, Inc. since January 1, 2019. Ms. Wulf served as Senior Vice President and President of the Manufacturing Division at US Foods, Inc. since 2011. Ms. Wulf served as Chief of food safety business unit of Nutrition Physiology Corporation since January 2010. Previously, Ms. Wulf served as Senior Vice President and Assistant to the Chief Executive Officer at Tyson Foods, Inc., of Springdale, Ark. There, she led growth and turnaround initiatives domestically and internationally. She also served as General Manager for Tyson's deli business, and was responsible for its bottom line and growth strategies. Prior to her tenure at Tyson Foods, Ms. Wulf led business components of Bakery Chef, a Chicago-based frozen foods manufacturer; Sara Lee Coffee and Tea of Downers Grove, Ill.; Pillsbury Bakeries & Food Service of Minneapolis; Bunge Foods Corporation of White Plains, N.Y.; and Decatur, Ill.-based Tate & Lyle. she serves as Member of Board of Directors and the Executive Committee of the National Fisheries Institute. Ms. Wulf serves on the board of directors for the Women's Foodservice Forum and as a board member of the International Foodservice Manufacturers Association. Ms. Wulf earned a Bachelor's degree in finance from Western Illinois University in Macomb, Ill., and an M.B.A. from DePaul University in Chicago.

CEO Compensation
  • Insufficient data for Sylvia to compare compensation growth.
  • Insufficient data for Sylvia to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the AquaBounty Technologies management team in years:

4.6
Average Tenure
59
Average Age
  • The tenure for the AquaBounty Technologies management team is about average.
Management Team

David Frank

TITLE
CFO & Treasurer
COMPENSATION
$308K
AGE
58
TENURE
11.6 yrs

Ron Stotish

TITLE
Executive Director & Chief Technology Officer
COMPENSATION
$472K
AGE
69
TENURE
0.3 yrs

Alejandro Rojas

TITLE
Chief Operating Officer of Aquabounty Farms
COMPENSATION
$284K
AGE
56
TENURE
5.3 yrs

Sylvia Wulf

TITLE
CEO, President & Executive Director
AGE
60
TENURE
0.3 yrs

Christopher Martin

TITLE
General Counsel & Company Secretary
AGE
52
TENURE
3.9 yrs

Dave Conley

TITLE
Director of Communications

Henry Clifford

TITLE
Vice President of Sales & Marketing
COMPENSATION
$270K
AGE
64
TENURE
13.9 yrs

Louis Barnett

TITLE
Financial Advisor
Board of Directors Tenure

Average tenure and age of the AquaBounty Technologies board of directors in years:

6
Average Tenure
65
Average Age
  • The tenure for the AquaBounty Technologies board of directors is about average.
Board of Directors

Richard Clothier

TITLE
Chairman of the Board
COMPENSATION
$92K
AGE
73
TENURE
13.1 yrs

Ron Stotish

TITLE
Executive Director & Chief Technology Officer
COMPENSATION
$472K
AGE
69
TENURE
11 yrs

Sylvia Wulf

TITLE
CEO, President & Executive Director
AGE
60
TENURE
0.3 yrs

Dick Huber

TITLE
Independent Director
COMPENSATION
$64K
AGE
81
TENURE
13.3 yrs

Christine St. Clare

TITLE
Independent Director
COMPENSATION
$64K
AGE
68
TENURE
5 yrs

James Turk

TITLE
Independent Director
COMPENSATION
$49K
AGE
62
TENURE
6.3 yrs

Rick Sterling

TITLE
Director
AGE
54
TENURE
5.7 yrs

Jeff Perez

TITLE
Non-Executive Director
AGE
46
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess AquaBounty Technologies's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. AquaBounty Technologies has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.

Details
Name: AquaBounty Technologies, Inc.
W8NB
Exchange: BST
Founded: 1991
$42,560,817
21,598,555
Website: http://www.aquabounty.com
Address: AquaBounty Technologies, Inc.
Two Mill & Main Place,
Suite 395,
Maynard,
Massachusetts, 01754,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM AQB Common Stock Nasdaq Capital Market US USD 11. Nov 2014
BST W8NB Common Stock Boerse-Stuttgart DE EUR 11. Nov 2014
LSE AQB COM USD0.001 (DI) London Stock Exchange GB USD 21. May 2019
Number of employees
Current staff
Staff numbers
44
AquaBounty Technologies employees.
Industry
Biotechnology
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/21 23:08
End of day share price update: 2019/05/21 00:00
Last estimates confirmation: 2019/05/10
Last earnings filing: 2019/05/02
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.